Global Daptomycin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Daptomycin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.
Daptomycin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Daptomycin market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Adult and Pediatric Patients (1 to 17 years of age) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Daptomycin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Daptomycin key manufacturers include Merck & Co., Pfizer, Teva, Mylan, Fresenius Kabi, Sagent Pharmaceuticals, Xellia, Hisun and HENGRUI PHARMA, etc. Merck & Co., Pfizer, Teva are top 3 players and held % sales share in total in 2022.
Daptomycin can be divided into 350 mg Lyophilized Powder and 500 mg Lyophilized Powder, etc. 350 mg Lyophilized Powder is the mainstream product in the market, accounting for % sales share globally in 2022.
Daptomycin is widely used in various fields, such as Adult and Pediatric Patients (1 to 17 years of age), etc. Adult provides greatest supports to the Daptomycin industry development. In 2022, global % sales of Daptomycin went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Daptomycin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine
Segment by Type
350 mg Lyophilized Powder
500 mg Lyophilized Powder
Adult
Pediatric Patients (1 to 17 years of age)
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Daptomycin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Daptomycin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Daptomycin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Daptomycin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Daptomycin introduction, etc. Daptomycin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Daptomycin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Daptomycin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Daptomycin market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Adult and Pediatric Patients (1 to 17 years of age) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Daptomycin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Daptomycin key manufacturers include Merck & Co., Pfizer, Teva, Mylan, Fresenius Kabi, Sagent Pharmaceuticals, Xellia, Hisun and HENGRUI PHARMA, etc. Merck & Co., Pfizer, Teva are top 3 players and held % sales share in total in 2022.
Daptomycin can be divided into 350 mg Lyophilized Powder and 500 mg Lyophilized Powder, etc. 350 mg Lyophilized Powder is the mainstream product in the market, accounting for % sales share globally in 2022.
Daptomycin is widely used in various fields, such as Adult and Pediatric Patients (1 to 17 years of age), etc. Adult provides greatest supports to the Daptomycin industry development. In 2022, global % sales of Daptomycin went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Daptomycin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck & Co.
Pfizer
Teva
Mylan
Fresenius Kabi
Sagent Pharmaceuticals
Xellia
Hisun
HENGRUI PHARMA
Huadong Medicine
Segment by Type
350 mg Lyophilized Powder
500 mg Lyophilized Powder
Segment by Application
Adult
Pediatric Patients (1 to 17 years of age)
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Daptomycin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Daptomycin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Daptomycin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Daptomycin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Daptomycin introduction, etc. Daptomycin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Daptomycin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices